Cargando…

Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype

BACKGROUND: Freezing in the levodopa-medicated-state (ON-state) is a debilitating feature of Parkinson’s disease without treatment options. Studies detailing the distinguishing features between people with freezing of gait that improves with levodopa and those whose freezing continues even on levodo...

Descripción completa

Detalles Bibliográficos
Autores principales: Landes, Reid D., Glover, Aliyah, Pillai, Lakshmi, Doerhoff, Shannon, Virmani, Tuhin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162361/
https://www.ncbi.nlm.nih.gov/pubmed/35653359
http://dx.doi.org/10.1371/journal.pone.0269227
_version_ 1784719686325239808
author Landes, Reid D.
Glover, Aliyah
Pillai, Lakshmi
Doerhoff, Shannon
Virmani, Tuhin
author_facet Landes, Reid D.
Glover, Aliyah
Pillai, Lakshmi
Doerhoff, Shannon
Virmani, Tuhin
author_sort Landes, Reid D.
collection PubMed
description BACKGROUND: Freezing in the levodopa-medicated-state (ON-state) is a debilitating feature of Parkinson’s disease without treatment options. Studies detailing the distinguishing features between people with freezing of gait that improves with levodopa and those whose freezing continues even on levodopa are lacking. OBJECTIVE: To characterize the gross motor, gait, and non-motor features of this phenotype. METHODS: Instrumented continuous gait was collected in the levodopa-medicated-state in 105 patients: 43 non-freezers (no-FOG), 36 with freezing only OFF-levodopa (OFF-FOG) and 26 with freezing both ON- and OFF-levodopa (ONOFF-FOG). Evaluation of motor and non-motor disease features was undertaken using validated scales. A linear mixed model with age, sex, disease duration, and motor UPDRS scores as covariates was used to determine differences in spatiotemporal gait and non-motor disease features among the groups. RESULTS: Compared to OFF-FOG, the ONOFF-FOG group had greater disease severity (on the Unified Parkinson’s disease Rating Scale) and worse cognition (on the Montreal Cognitive Assessment, Frontal Assessment Battery and Scales for Outcome in Parkinson’s disease-Cognition scales) and quality of life (on the PDQ-39), but similar mood (on the Hamilton depression and anxiety scales) and sleep quality (on Epworth sleepiness scale and RBD questionnaire). For several gait features, differences between the ONOFF-OFF groups were at least as large and in the opposite direction as differences between OFF-no groups, controlling for disease severity. Variability in ONOFF-FOG was greater than in other groups. Using results from our study and others, a power analysis for a potential future study reveals sample sizes of at least 80 ONOFF and 80 OFF-FOG patients would be needed to detect clinically meaningful differences. CONCLUSIONS: Intra-patient variability in spatiotemporal gait features was much greater in ONOFF-FOG than in the other two groups. Our results suggest that multifactorial deficits may lead to ONOFF-FOG development.
format Online
Article
Text
id pubmed-9162361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91623612022-06-03 Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype Landes, Reid D. Glover, Aliyah Pillai, Lakshmi Doerhoff, Shannon Virmani, Tuhin PLoS One Research Article BACKGROUND: Freezing in the levodopa-medicated-state (ON-state) is a debilitating feature of Parkinson’s disease without treatment options. Studies detailing the distinguishing features between people with freezing of gait that improves with levodopa and those whose freezing continues even on levodopa are lacking. OBJECTIVE: To characterize the gross motor, gait, and non-motor features of this phenotype. METHODS: Instrumented continuous gait was collected in the levodopa-medicated-state in 105 patients: 43 non-freezers (no-FOG), 36 with freezing only OFF-levodopa (OFF-FOG) and 26 with freezing both ON- and OFF-levodopa (ONOFF-FOG). Evaluation of motor and non-motor disease features was undertaken using validated scales. A linear mixed model with age, sex, disease duration, and motor UPDRS scores as covariates was used to determine differences in spatiotemporal gait and non-motor disease features among the groups. RESULTS: Compared to OFF-FOG, the ONOFF-FOG group had greater disease severity (on the Unified Parkinson’s disease Rating Scale) and worse cognition (on the Montreal Cognitive Assessment, Frontal Assessment Battery and Scales for Outcome in Parkinson’s disease-Cognition scales) and quality of life (on the PDQ-39), but similar mood (on the Hamilton depression and anxiety scales) and sleep quality (on Epworth sleepiness scale and RBD questionnaire). For several gait features, differences between the ONOFF-OFF groups were at least as large and in the opposite direction as differences between OFF-no groups, controlling for disease severity. Variability in ONOFF-FOG was greater than in other groups. Using results from our study and others, a power analysis for a potential future study reveals sample sizes of at least 80 ONOFF and 80 OFF-FOG patients would be needed to detect clinically meaningful differences. CONCLUSIONS: Intra-patient variability in spatiotemporal gait features was much greater in ONOFF-FOG than in the other two groups. Our results suggest that multifactorial deficits may lead to ONOFF-FOG development. Public Library of Science 2022-06-02 /pmc/articles/PMC9162361/ /pubmed/35653359 http://dx.doi.org/10.1371/journal.pone.0269227 Text en © 2022 Landes et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Landes, Reid D.
Glover, Aliyah
Pillai, Lakshmi
Doerhoff, Shannon
Virmani, Tuhin
Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title_full Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title_fullStr Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title_full_unstemmed Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title_short Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
title_sort levodopa onoff-state freezing of gait: defining the gait and non-motor phenotype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162361/
https://www.ncbi.nlm.nih.gov/pubmed/35653359
http://dx.doi.org/10.1371/journal.pone.0269227
work_keys_str_mv AT landesreidd levodopaonoffstatefreezingofgaitdefiningthegaitandnonmotorphenotype
AT gloveraliyah levodopaonoffstatefreezingofgaitdefiningthegaitandnonmotorphenotype
AT pillailakshmi levodopaonoffstatefreezingofgaitdefiningthegaitandnonmotorphenotype
AT doerhoffshannon levodopaonoffstatefreezingofgaitdefiningthegaitandnonmotorphenotype
AT virmanituhin levodopaonoffstatefreezingofgaitdefiningthegaitandnonmotorphenotype